Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Hypoxia is a hallmark of oral squamous cell carcinoma (OSCC) and plays a critical role in driving tumor progression. However, the mechanisms by which OSCC cells respond to hypoxic signaling to promote malignant phenotypes remain unclear. The present study aimed to identify the key regulatory factors governing hypoxic adaptation in OSCC. Based on bulk RNA‑sequencing (RNA‑seq) data from The Cancer G...
Artificial intelligence (AI) is reshaping cancer research and clinical oncology by enabling large-scale analysis of complex biomedical data. Although early AI efforts focused on single-modality tasks such as imaging interpretation or pathology classification, contemporary oncology increasingly requires integrated reasoning across heterogeneous inputs, including imaging, digital pathology, and geno...
Glioma is a primary tumor derived from central nervous system glial cells. RNA binding motif protein 25 (RBM25) has been implicated in glioma progress...
Vasoactive intestinal peptide (VIP) plays a multifaceted role in cancer biology, yet its prognostic and immunological implications in melanoma remain ...
The construction of 3D in vitro tumor models centered on bioprinting technology represents one of the most anticipated interdisciplinary innovations a...
PURPOSE: The purpose of this study was to use transmission electron miscroscopy images to develop a deep-learning-based artificial intelligence model ...
This collection of reviews and research articles highlights the diagnostic and therapeutic potential of gut microbial metabolites across various gastr...
BACKGROUND: Accurate preoperative differentiation between benign and malignant parotid gland tumors is essential for guiding surgical planning and tre...
BACKGROUND: Warfarin dosing in cancer patients is challenging due to altered pathophysiology and variable responses. While machine learning offers pre...
Sleep medicine has rapidly adopted artificial intelligence, but most applications still prioritize automated sleep staging or single summary indices, ...
Background Acute myeloid leukemia (AML) remains a lethal hematologic malignancy with high heterogeneity. Macrophage-mediated efferocytosis in the tumo...
OBJECTIVE: Artificial intelligence (AI) is transforming medical imaging and radiation oncology, yet limited understanding and access to education hind...
Cancer therapeutics account for a significant proportion of new drug development, reflecting advances in diagnosis, treatment, and disease control. Ho...
PURPOSE: Patients with prostate cancer (PC) face elevated cardiovascular (CV) risk. Conventional CV risk scores are often poorly calibrated for PC and...
Glioblastoma exhibits profound intratumoral heterogeneity and rapid adaptation under stress, complicating durable therapeutic control. Here, a biologi...
Brain tumors remain a major public health challenge because of their high mortality rate and the need for timely and accurate diagnosis. Magnetic Reso...
BACKGROUND AND OBJECTIVE: Neoadjuvant immune-checkpoint inhibitors (ICIs) in muscle-invasive bladder cancer (MIBC) were tested in patient's ineligible...
Non-muscle-invasive bladder cancer (NMIBC) has high rates of recurrence and progression, yet its molecular landscape across different ethnicities rema...
Human Heparanase (HPSE), the only mammalian endo-β-D-glucuronidase, plays an important role in extracellular matrix remodeling and the release of hepa...
Accurate assessment of lymph node metastasis (LNM) following neoadjuvant chemoradiotherapy (nCRT) presents a significant clinical challenge and is ess...